Roxana Kostici

Dr. Roxana Kostici


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ABAndrei Bita
Andrei Bita
ISIon Romulus Scorei
Ion Romulus Scorei
Marvin A. Soriano-UrsuaMarvin A. Soriano-Ursua
Marvin A. Soriano-Ursua
GMGeorge Dan Mogoşanu
George Dan Mogoşanu
IBIonela Belu
Ionela Belu
Dan Ionuţ GheoneaDan Ionuţ Gheonea
Dan Ionuţ Gheonea
Precision nutrition-targeted gut microbiota (GM) may have therapeutic potential not only for age-related diseases but also for slowing the aging process and promoting longer healthspan. Recent studies have shown that restoring a healthy symbiosis of GM by counteracting dysbiosis (DYS) through precise nutritional intervention is becoming a major target for extending healthspan. Microbiota-accessible borate (MAB) complexes, such as boron (B)–pectins (rhamnogalacturonan–borate) and borate–phenolic esters (diester chlorogenoborate), have a significant impact on healthy host–microbiota symbiosis (HMS). The mechanism of action of MABs involves the biosynthesis of the autoinducer-2–borate (AI-2B) signaling molecule, B fortification of the mucus gel layer by the MABs diet, inhibition of pathogenic microbes, and reversal of GM DYS, strengthening the gut barrier structure, enhancing immunity, and promoting overall host health. In fact, the lack of MAB complexes in the human diet causes reduced levels of AI-2B in GM, inhibiting the Firmicutes phylum (the main butyrate-producing bacteria), with important effects on healthy HMS. It can now be argued that there is a relationship between MAB-rich intake, healthy HMS, host metabolic health, and longevity. This could influence the deployment of natural prebiotic B-based nutraceuticals targeting the colon in the future. Our review is based on the discovery that MAB diet is absolutely necessary for healthy HMS in humans, by reversing DYS and restoring eubiosis for longer healthspan.

7 August 2025 in Polymers
Verified
Journal Article
Open access
PDF file
ASAna-Maria Stanoiu
Ana-Maria Stanoiu
CBCornelia Bejenaru
Cornelia Bejenaru
ASAdina-Elena Segneanu
Adina-Elena Segneanu
GVGabriela Vlase
Gabriela Vlase
IBIonela Amalia Bradu
Ionela Amalia Bradu
LBLudovic Everard Bejenaru
Ludovic Everard Bejenaru
Inonotus obliquus, a medicinal mushroom valued for its bioactive compounds, has not been previously characterized from Romanian sources. This study presents the first comprehensive chemical and biological screening of I. obliquus, introducing novel polymer-based encapsulation systems to enhance the stability and bioavailability of its bioactive constituents. Two distinct delivery systems were designed to enhance the functionality of I. obliquus extracts: (i) microencapsulation in maltodextrin (MIO) and (ii) a sequential approach involving preparation of silver nanoparticle-loaded I. obliquus (IO–AgNPs), followed by microencapsulation to yield the hybrid MIO–AgNP system. Comprehensive metabolite profiling using GC–MS and ESI–QTOF–MS revealed 142 bioactive constituents, including terpenoids, flavonoids, phenolic acids, amino acids, coumarins, styrylpyrones, fatty acids, and phytosterols. Structural integrity and successful encapsulation were confirmed by XRD, FTIR, and SEM analyses. Both IO–AgNPs and MIO–AgNPs demonstrated potent antioxidant activity, significant acetylcholinesterase inhibition, and robust antimicrobial effects against Staphylococcus aureus, Bacillus cereus, Pseudomonas aeruginosa, and Escherichia coli. Cytotoxicity assays revealed pronounced activity against MCF-7, HCT116, and HeLa cell lines, with MIO–AgNPs exhibiting superior efficacy. The synergistic integration of maltodextrin and AgNPs enhanced compound stability and bioactivity. As the first report on Romanian I. obliquus, this study highlights its therapeutic potential and establishes polymer-based nanoencapsulation as an effective strategy for optimizing its applications in combating microbial resistance and cancer.

15 March 2026 in Plants
Verified
Journal Article
Open access
PDF file
ASAdina-Elena Segneanu
Adina-Elena Segneanu
GMGeorge Dan Mogoşanu
George Dan Mogoşanu
CBCornelia Bejenaru
Cornelia Bejenaru
RKRoxana Kostici
Roxana Kostici
LBLudovic Everard Bejenaru
Ludovic Everard Bejenaru
Plant-derived extracellular vesicles (PDEVs), engineered phytosomes, bioinspired polymeric plant-based nanoparticles (PBNPs), hybrid phyto-inorganic nanocomposites, green-synthesized metal nanoparticles, self-assembled nanoarchitectures, and multifunctional composites represent a rapidly advancing class of sustainable, nature-inspired nanocarriers. These platforms combine exceptional biocompatibility, negligible immunogenicity, and renewable sourcing with tunable drug loading, targeted delivery, and controlled release properties. This review synthesizes translational advances from 2020 to 2026, covering scalable isolation/bioprocessing (bioreactors, elicitation), multi-parametric physicochemical/multi-omics characterization, rational engineering/hybridization, and rigorous in vitro/in vivo assessments of uptake, biodistribution, pharmacokinetic (PK), and efficacy. Phytosomes and PBNPs markedly enhance oral bioavailability and targeted delivery of lipophilic phytochemicals, while PDEVs offer unique immunomodulatory, anti-inflammatory, and gene-regulatory activities. Hybrid and green-synthesized systems provide structural stability, redox modulation, and synergistic effects, and self-assembled/multifunctional composites address solubilization barriers with stimuli-responsive design. Early-phase human studies on grapefruit-, ginger-, turmeric-, and ginseng-derived PDEVs report excellent short-term safety, favorable PK, and preliminary bioactivity signals, with no observed immunogenicity or dose-limiting toxicities; however, these trials remain exploratory, constrained by small sample sizes and safety-focused endpoints. Despite challenges, including methodological heterogeneity, variable yields, long-term safety uncertainties (notably for inorganic hybrids), and regulatory ambiguities, emerging strategies such as clustered regularly interspaced short palindromic repeats (CRISPR)-engineered plant line; artificial-intelligence-driven process optimization; standardized guidelines, and integrated clinical, intellectual property, and commercialization frameworks are progressively addressing these barriers. Collectively, these advances position plant-derived nanocarriers as immunologically privileged, eco-friendly alternatives to synthetic and mammalian platforms, laying the foundation for a sustainable era of precision phytomedicine.

1 July 2026 in Molecules
Verified
Journal Article
Open access
PDF file
RKRoxana Kostici
Roxana Kostici
AKAdina Maria Kamal
Adina Maria Kamal
DTDiana Maria Trasca
Diana Maria Trasca
CVCarmen Vladulescu
Carmen Vladulescu
Renata Maria VarutRenata Maria Varut
Renata Maria Varut
DPDenisa Pirscoveanu
Denisa Pirscoveanu
Diabetes mellitus represents a major global health burden, necessitating the development of safer and more effective therapeutic alternatives. Medicinal plants have gained increasing attention due to their bioactive compounds with potential hypoglycemic and antioxidant effects. The present study aimed to investigate the physicochemical characteristics, phytochemical composition, antioxidant capacity, and toxicological profile of hydroalcoholic tinctures obtained from Agrimonia pilosa Ledeb., Calendula arvensis L., and Polygonum hydropiper L. The tinctures were prepared by simple percolation using 70% ethanol and evaluated according to pharmacopoeial standards, including organoleptic properties, relative density, refractive index, alcohol content, and purity parameters. Phytochemical analysis was performed using thin-layer chromatography and spectrophotometric methods, highlighting the presence of flavonoids and polyphenolcarboxylic acids, with several bands showing chromatographic and spectral similarities to chlorogenic and caffeic acid standards. Antioxidant activity was assessed through total polyphenol and flavonoid content, with Polygonum hydropiper exhibiting the highest values. The hypoglycemic effect was evaluated using the oral glucose tolerance test in normoglycemic mice, demonstrating significant reductions in blood glucose levels, particularly for Agrimonia pilosa at higher doses. Acute toxicity studies indicated a low toxicity profile, with no mortality observed even at high doses (up to 9 g/kg body weight), corresponding to GHS category 5. However, subacute toxicity assessment revealed species-dependent effects, ranging from minimal hepatic changes for Calendula arvensis to moderate hepatotoxicity for Polygonum hydropiper and more pronounced hepatic, renal, and pancreatic alterations for Agrimonia pilosa. These findings suggest that the investigated tinctures possess significant hypoglycemic and antioxidant potential, with generally favorable safety profiles following acute administration. Nevertheless, prolonged use may induce organ-specific toxicity, highlighting the need for further pharmacological and clinical investigations to establish their therapeutic applicability and safety in diabetes management.

Verified
Journal Article
Open access
PDF file
RKRoxana Kostici
Roxana Kostici
DPDenisa Pirscoveanu
Denisa Pirscoveanu
DTDiana Maria Trasca
Diana Maria Trasca
AKAdina Maria Kamal
Adina Maria Kamal
Renata Maria VarutRenata Maria Varut
Renata Maria Varut
GSGeorge-Alin Stoica
George-Alin Stoica
Background: Oxidative stress, dyslipidemia, weight loss, and tissue injury accompany sustained hyperglycemia and provide complementary endpoints for evaluating botanical interventions. This study compared hydroalcoholic extracts of Agrimonia pilosa, Calendula arvensis, and Polygonum hydropiper with Vaccinium myrtillus as a positive botanical control in a mouse model of streptozotocin-induced diabetes. Methods: Thirty male CD1 mice aged 4–6 weeks were studied in six groups of five animals. Diabetes was induced by a single intraperitoneal administration of streptozotocin at 180 mg/kg body weight. Fasting blood glucose was measured before streptozotocin administration, 72 h and one week after injection. Animals showing fasting blood glucose concentrations >300 mg/dL, confirmed by repeated measurement, were considered diabetic and included in the chronic treatment experiment. Following confirmation of diabetes, hydroalcoholic tinctures were administered orally once daily for 35 days at the previously selected doses: A. pilosa 200 mg/kg, C. arvensis 150 mg/kg, P. hydropiper 100 mg/kg, and V. myrtillus 100 mg/kg as an active botanical comparator. Glycemia and body mass were followed longitudinally; food and water intake were recorded weekly. Whole-blood lipids, malondialdehyde (MDA), total antioxidant capacity (TAC), superoxide dismutase (SOD), glutathione peroxidase (GPx), albumin, and creatinine were assessed, together with histopathology. Animal-level between-group comparisons used two-sided Welch independent-samples t-tests; glycemic treatment-versus-untreated-STZ comparisons were Bonferroni-adjusted. Food and water intake were summarized descriptively because they were recorded at cage level. Results: At day 35, mean glycemia was 358.60 mg/dL in untreated diabetic mice and 122.00, 177.20, 252.20, and 174.80 mg/dL after A. pilosa, P. hydropiper, C. arvensis, and V. myrtillus, respectively. A. pilosa had the lowest glucose mean among survivors, but two animals died, leaving n = 3 at days 28 and 35 and a potential for survivor bias. P. hydropiper showed higher SOD and GPx activities in exploratory pairwise analyses, whereas C. arvensis had the lowest day-35 triglyceride mean. Histopathology revealed hepatic alterations in several treatment groups and myocardial interfascicular edema in P. hydropiper and V. myrtillus; these findings were descriptive and were not used for between-group severity ranking. Conclusions: The extracts showed distinct exploratory activity profiles. P. hydropiper was associated with a numerical glycemic reduction and higher SOD and GPx activities in exploratory pairwise analyses, whereas C. arvensis produced the lowest day-35 triglyceride concentration. A. pilosa showed the largest numerical reduction in glycemia among the surviving animals; however, mortality observed in the A. pilosa group during treatment and the resulting final sample of three animals precluded firm conclusions regarding comparative efficacy.

13 June 2026 in Molecules
Verified
Journal Article
Open access
PDF file
RKRoxana Kostici
Roxana Kostici
DPDenisa Pirscoveanu
Denisa Pirscoveanu
DTDiana Maria Trasca
Diana Maria Trasca
AKAdina Maria Kamal
Adina Maria Kamal
CVCarmen Vladulescu
Carmen Vladulescu
GPGabriela Pura
Gabriela Pura
Background/Objectives: Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia, dyslipidemia, and oxidative stress, leading to severe systemic complications. Medicinal plants rich in polyphenolic compounds have gained increasing attention as complementary therapeutic agents. This study aimed to comparatively evaluate the chemical composition, as well as the antidiabetic, hypolipidemic, and antioxidant effects of Polygonum persicaria and Vaccinium myrtillus in a streptozotocin-induced diabetic model. Although Vaccinium myrtillus has been more extensively investigated for its antidiabetic potential, the pharmacological relevance of Polygonum persicaria in diabetes remains insufficiently characterized, particularly in direct comparison with a recognized phytotherapeutic comparator. Methods: Hydroalcoholic tinctures prepared from Polygonum persicaria L. herb and Vaccinium myrtillus L. leaves were subjected to phytochemical analysis using High-Performance Thin-Layer Chromatography (HPTLC) for the identification of flavonoids and phenolcarboxylic acids, alongside spectrophotometric determination of total polyphenol and flavonoid content. Experimental diabetes was induced in CD1 mice by streptozotocin administration. Animals were treated orally for 35 days, and glycemic parameters, lipid profile, body weight, food and water intake, and oxidative stress markers (MDA, SOD, TAC, and GPx) were evaluated. Results: HPTLC/CSS screening indicated the presence of rutin, chlorogenic acid, and caffeic acid in Polygonum persicaria, while Vaccinium myrtillus showed stronger densitometric signals for phenolcarboxylic acid-type compounds, particularly chlorogenic and caffeic acids. Total polyphenol and flavonoid content were also higher in Vaccinium myrtillus (433.89 ± 8.67 mg/L GAE; 154.38 ± 3.08 mg/L QE) compared to Polygonum persicaria (269.28 ± 5.25 mg/L GAE; 132.75 ± 2.65 mg/L QE). Functionally, Vaccinium myrtillus demonstrated a significant antihyperglycemic effect from day 14 (p = 0.009) and improved lipid parameters, while Polygonum persicaria showed a delayed glycemic effect, significant only at day 35 (p = 0.014), without significant hypolipidemic activity. In contrast, Polygonum persicaria exerted a marked antioxidant effect, significantly increasing GPx activity (p = 0.025) and reducing MDA levels (p = 0.053). Conclusions: Vaccinium myrtillus showed stronger antihyperglycemic and hypolipidemic effects, while Polygonum persicaria was mainly associated with antioxidant-related biochemical changes. These differences may be influenced by phytochemical composition, but they cannot be attributed solely to total polyphenol or flavonoid content.